CureVac to Present at the 12th International mRNA Health Conference

1 year ago

TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / November 4, 2024 / CureVac N.V. (Nasdaq:CVAC) ("CureVac"), a global biopharmaceutical company…

NLS Pharmaceutics and Kadimastem Enter into a Definitive Merger Agreement

1 year ago

ZURICH, SWITZERLAND and NESS ZIONA, ISRAEL / ACCESSWIRE / November 4, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP) ("NLS"), a biopharmaceutical…

Philips enrolls first patient in U.S. clinical trial for innovative integrated single-device to treat peripheral artery disease

1 year ago

THOR Integrated Device With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device,…

Myriad Genetics Comments on UnitedHealthcare’s Updated Medical Policy for Pharmacogenetic Testing

1 year ago

SALT LAKE CITY, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and…

Renovaro Issues Shareholder Letter and Provides Corporate Update

1 year ago

LOS ANGELES, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: RENB), a pioneer in cancer diagnostics and therapeutics powered…

Surrozen and TCGFB, Inc. Announce Strategic Research Collaboration to Develop TGF-β Antibodies for Idiopathic Pulmonary Fibrosis

1 year ago

Research collaboration to leverage Surrozen’s antibody research capabilities and expertise to discover a potential first in class treatment for patients…

IRADIMED CORPORATION Named to Fortune’s 100 Fastest Growing Companies List for 2024

1 year ago

WINTER SPRINGS, Fla., Nov. 04, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) was recently named one of…

Parity Healthcare Analytics joins Synova to support safe, financially sustainable nurse staffing

1 year ago

ROCKVILLE, Md., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Parity Healthcare Analytics has joined Synova Associates as a top-tier Premium Industry…

CytoDyn Announces FDA Clearance of Its Phase II Oncology Trial

1 year ago

VANCOUVER, Washington, Nov. 04, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing…

CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium

1 year ago

BERKELEY HEIGHTS, N.J., Nov. 04, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and…